US-based Prometrika and Comprehend Systems have announced a partnership to address the changing needs of biotech and pharmaceutical sponsors that run clinical trials.

Prometrika noted that many of its clients were requesting improved data analytics and reporting capabilities.

Sponsors are moving away from traditional data reporting toward the ability to compare data from multiple studies within a programme. The traditional reporting was exclusive to a single study,

Prometrika president and CEO Miganush Stepanians said: “Comprehend aligns with our mission of helping sponsors achieve successful clinical development through advances in data science.

“After an extensive review process, we selected Comprehend’s Clinical Intelligence Suite for its clinical-focused functionality, ease of deployment, and overall cost effectiveness. The solution is the best fit for our business and meets the evolving needs of our clients.”

Comprehend’s solutions are used by Prometrika to collect data from multiple sources such as EDC, Labs, CTMS, ePRO, IxRS, and eTMF, and update the sourced data in real time and deliver on-demand dynamic line listings and graphical patient profiles within and across studies.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Stepanians further added: “Our clients are now able to securely explore their own data, with visibility into multiple data sets in a single view, and run descriptive analytics customized for their medical data review and centralized monitoring strategies.”

Industry surveys reveal global desire for data unification, improved visibility, and cross-study comparisons, yet very few sponsors use data with any regularity.

Comprehend founder and president Rick Morrison said that CROs such as Prometrika can gain advantage by steering sponsors toward solutions that make clinical research effective.